Search Results for "Dexpak Pak 10 Day Multiple Sclerosis"
Original Source: Dexamethasone [ECR Pharmaceuticals]
Dexamethasone 10 Day Pack
Matching Channels
Multiple sclerosis (MS) is the most common disabling neurological condition affecting 100,000 young adults in the UK. The condition results from autoimmune damage to myelin, causing interference i...
ATX-MS-1467 for patients with multiple sclerosis (MS)
ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the...
Matching News
ECR Pharmaceuticals re-launches Zolpimist Oral Spray, DexPak Taperpaks
Hi-Tech Pharmacal through its ECR Pharmaceuticals division has re-launched Zolpimist Oral Spray (zolpidem tartrate) and DexPak Taperpaks (dexamethasone tablets).
EpiCast Report: Multiple Sclerosis - Epidemiology Forecast to 2022
EpiCast Report: Multiple Sclerosis - Epidemiology Forecast to 2022 Summary Multiple sclerosis (MS) is an inflammatory disease in which the myelin sheaths around the axons of the brain and spinal cord...
Nanoparticle Halts Multiple Sclerosis in mice
In a breakthrough for nanotechnology and multiple sclerosis, a biodegradable nanoparticle turns out to be the perfect vehicle to stealthily deliver an antigen that tricks the immune system into stoppi...
New nanoparticle halts relapsing remitting multiple sclerosis in mouse model
In a breakthrough for nanotechnology and multiple sclerosis, a biodegradable nanoparticle turns out to be the perfect vehicle to stealthily deliver an antigen that tricks the immune system into stoppi...
Researchers define two categories of multiple sclerosis patients
There are approximately 400,000 people in the United States with multiple sclerosis. Worldwide, the number jumps to more than 2.1 million people. Rather than a one-size-fits-all approach to treating t...
Researchers define 2 categories of multiple sclerosis patients
BOSTON, MA—There are approximately 400,000 people in the United States with multiple sclerosis. Worldwide, the number jumps to more than 2.1 million people. Rather than a one-size-fits-all approach...
Discovery of immune cells that protect against multiple sclerosis offers hope for new treatment
In multiple sclerosis, the immune system attacks nerves in the brain and spinal cord, causing movement problems, muscle weakness and loss of vision. Immune cells called dendritic cells, which were pre...
Multiple Sclerosis Yielding Secrets But Questions Remain
More than two million people worldwide have multiple sclerosis (MS). In a worrying trend, the number of new patients appears to be increasing - especially the number of women, compared with men, devel...
Matching PubMed Articles
Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis.
Retrovirus-like particles containing the multiple sclerosis-associated retrovirus RNA, significantly found in the cerebrospinal fluid of patients with multiple sclerosis, have been preliminarily assoc...
Multiple sclerosis: Is multiple sclerosis caused by venous insufficiency?
The management of multiple sclerosis in children: a European view.
About 3-5% of all patients with multiple sclerosis experience the onset of their disease under the age of 16. A significant proportion of paediatric multiple sclerosis patients develop significant cog...
Background: Multiple sclerosis is a presumed autoimmune disease associated with genetic and environmental risk factors such as infectious mononucleosis. Recent research has shown infectious mononucleo...
Alerting Network Dysfunction in Early Multiple Sclerosis.
The objective of this study is to assess attention in recently diagnosed relapsing-remitting multiple sclerosis patients. Twenty-seven patients with early multiple sclerosis and low clinical disabilit...
